ARPO - Aerpio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue20,157.43---
Cost of Revenue----
Gross Profit20,157.43---
Operating Expenses
Research Development17,852.75612,147.13211,367.5911,625.404
Selling General and Administrative13,485.9189,241.4115,265.9955,861.151
Non Recurring----
Others----
Total Operating Expenses31,338.67421,388.54316,633.58517,486.555
Operating Income or Loss-11,181.244-21,388.543-16,633.585-17,486.555
Income from Continuing Operations
Total Other Income/Expenses Net784.609-12.063-349.926416.332
Earnings Before Interest and Taxes-11,181.244-21,388.543-16,633.585-17,486.555
Interest Expense--105.782-482.204-482.204
Income Before Tax-10,396.635-21,400.606-16,983.511-17,070.223
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-10,396.635-21,400.606-16,983.511-17,070.223
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,396.635-21,400.606-16,983.511-17,070.223
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,396.635-22,343.903-20,912.088-17,418.659